A UCLA research team has found that long-term exposure to chlorpyrifos, a pesticide sprayed on crops across America, increases the risk of developing Parkinson's disease more than 2.5-fold. The study, published in Molecular Neurodegeneration, combines epidemiological evidence from more than 1,600 people with animal experiments that reveal exactly how the chemical harms the brain.
Chlorpyrifos has been used in agriculture for decades. Though residential uses were banned in 2001 and agricultural applications faced federal restrictions in 2021, the chemical remains active on fields in the United States and is still widely deployed elsewhere in the world. Researchers estimate that millions of Americans experienced significant exposure before those restrictions took effect.
The scale of risk became clear when UCLA researchers analyzed pesticide application records against residential and workplace addresses for 829 people with Parkinson's disease and 824 healthy controls, all enrolled in the university's long-running Parkinson's Environment and Genes study. Those with sustained household proximity to chlorpyrifos-treated fields showed dramatically elevated disease rates.
To understand the mechanism, researchers exposed mice to aerosolized chlorpyrifos over 11 weeks. The animals developed movement impairment and lost dopamine-producing neurons, the exact brain cells that deteriorate in Parkinson's patients. The team also detected brain inflammation and buildup of alpha-synuclein, a toxic protein that clumps in Parkinson's sufferers and disrupts normal neurological function.
The real breakthrough emerged from experiments in zebrafish. Researchers discovered that chlorpyrifos interferes with autophagy, the cell's internal garbage disposal and recycling system. This mechanism normally clears away damaged proteins and debris before they accumulate and cause injury. When chlorpyrifos shut down this cleanup process, neurons became defenseless against accumulating toxins. But when scientists manually restored autophagy or removed the synuclein protein in the experiments, nerve cells survived.
The implication is stark: the pesticide may trigger Parkinson's not through a direct toxin, but by clogging the brain's natural defense against protein buildup. This finding opens a new therapeutic avenue. If researchers can develop drugs to boost autophagy or clear toxic proteins more efficiently, they may be able to protect brains that have already been exposed.
Parkinson's disease affects nearly one million Americans and strikes when dopamine-producing neurons gradually fail. Early symptoms include tremors, muscle rigidity, slowed movement, and balance problems. Genetic predisposition plays a role, but environmental factors have increasingly emerged as major contributors. Pesticide exposure now ranks among the leading suspected culprits.
While chlorpyrifos use has declined in recent years domestically, the lag between exposure and disease onset means exposed individuals may develop symptoms decades after initial contact. The study raises the possibility that people with documented prior exposure could benefit from regular neurological screening. It also highlights similar pesticides still in use globally as candidates for similar scrutiny.
Dr. Jeff Bronstein, the study's senior author and a UCLA neurology professor, stated that the work moves chlorpyrifos from a general pesticide concern to a specific proven environmental risk factor. The identification of autophagy dysfunction as the culprit mechanism strengthens the causal link and suggests targets for intervention.
Author Jessica Williams: "This study transforms a suspected connection into a documented one, with a clear biological explanation that opens doors to prevention and treatment. For the millions who spent years near chlorpyrifos-treated fields, knowing the exact pathway of harm is both sobering and actionable."
Comments